<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">7906158</journal-id>
<journal-id journal-id-type="pubmed-jr-id">7844</journal-id>
<journal-id journal-id-type="nlm-ta">Trends Pharmacol Sci</journal-id>
<journal-id journal-id-type="iso-abbrev">Trends Pharmacol. Sci.</journal-id>
<journal-title-group>
<journal-title>Trends in pharmacological sciences</journal-title>
</journal-title-group>
<issn pub-type="ppub">0165-6147</issn>
<issn pub-type="epub">1873-3735</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30871735</article-id>
<article-id pub-id-type="pmc">6433515</article-id>
<article-id pub-id-type="doi">10.1016/j.tips.2019.02.003</article-id>
<article-id pub-id-type="manuscript">NIHMS1521280</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Adhesion G protein-coupled receptors as drug target for neurological
diseases</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Folts</surname>
<given-names>Christopher J.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Giera</surname>
<given-names>Stefanie</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Tao</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Piao</surname>
<given-names>Xianhua</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Division of Newborn Medicine, Department of Medicine,
Children’s Hospital and Harvard Medical School, Boston, MA 02115 USA</aff>
<aff id="A2"><label>2</label>Eli and Edythe Broad Center of Regeneration Medicine and
Stem Cell Research, University of California, San Francisco, San Francisco, CA
94143, USA</aff>
<aff id="A3"><label>3</label>Newborn Brain Research Institute, University of California
at San Francisco, San Francisco, CA 94158, USA</aff>
<aff id="A4"><label>4</label>Department of Pediatrics, University of California, San
Francisco, San Francisco, CA 94143, USA</aff>
<aff id="A5"><label>5</label>Current address: Vertex Pharmaceuticals, 50 Northern Ave.,
Boston, MA 02210</aff>
<aff id="A6"><label>6</label>Current address: Sanofi S.A., 49 New York Ave., Framingham,
MA 01701</aff>
<author-notes>
<corresp id="CR1"><label>*</label>Correspondence: Xianhua Piao, 35 Medical Center
Way, RMB, Pod D 1036, San Francisco, CA 94131;
<email>xianhua.piao@ucsf.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>12</day>
<month>2</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>11</day>
<month>3</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<month>4</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>4</month>
<year>2020</year>
</pub-date>
<volume>40</volume>
<issue>4</issue>
<fpage>278</fpage>
<lpage>293</lpage>
<!--elocation-id from pubmed: 10.1016/j.tips.2019.02.003-->
<abstract id="ABS1">
<p id="P1">The family of adhesion G protein-coupled receptors (aGPCRs) consists of
33 members in humans. Although the majority continue to be orphan receptors with
unknown functions, many reports have demonstrated critical functions for some
members of this family in organogenesis, neurodevelopment, myelination,
angiogenesis, and cancer progression. Importantly, mutations in several aGPCRs
have been linked to human diseases. The crystal structure of a shared protein
domain, the GPCR autoproteolysis inducing (GAIN) domain, has enabled the
discovery of a common signaling mechanism—a tethered agonist—for
this class of receptors. A series of recent reports has shed new light on their
biological functions and disease relevance. This review will focus on these
recent advances in our understanding of aGPCR biology in the nervous system and
the untapped potential of aGPCRs as novel therapeutic targets for neurological
disease.</p>
</abstract>
<kwd-group>
<kwd>Adhesion G protein-coupled receptors</kwd>
<kwd>aGPCRs</kwd>
<kwd>GPCR Autoproteolysis INducing (GAIN) domain</kwd>
<kwd>neurological disease</kwd>
<kwd>neurodevelopment</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>